111 In accordance with the Bye Laws for the EOS, the total number of shares which may be issued under the EOS to eligible participants, including Executive Directors and Senior Management of the Company, shall not exceed the aggregate of 2% of our Company’s total number of issued shares. Additionally, the total number of shares which may be issued under EOS options granted to a participant, who either singly or collectively with persons connected with him or her owns 20% or more of the total number of issued shares of our Company, shall not exceed in aggregate 10% of the total number of shares to be issued under the EOS. None of our Directors and Senior Management, either singly or collectively with persons connected with them, owns 20% or more of the total number of issued shares of our Company. Since the commencement of the EOS, the actual percentage of EOS options granted in aggregate to Executive Directors and Senior Management of the Company are 46% of the total number of EOS options granted. There were no EOS options granted to the Non-Executive Directors since the commencement dates of the EOS until FY2024. 3. Audit and Non-Audit Fees The amount of audit and non-audit fees paid or payable to external auditors by the Group and the Company respectively for FY2024 are as follows: Services rendered by KPMG PLT are not prohibited by regulatory and other professional requirements and are based on globally practised guidelines on auditors’ independence. 4. M aterial Contracts Involving Directors’, Chief Executive’s and Major Shareholders’ Interests Save as disclosed below and in the financial statements, there were no material contracts entered into by the Company and/or its subsidiaries involving Directors’, Chief Executive’s and Major Shareholders’ interests subsisting as at 31 December 2024 or entered into since the end of the previous financial year: • A shareholders’ agreement dated 23 December 2011 was entered into among the Company, Integrated Healthcare Hastaneler Turkey Sdn Bhd, Bagan Lalang Ventures Sdn Bhd, Hatice Seher Aydinlar and Mehmet Ali Aydinlar, whereby the parties have agreed on, among others, the rights and obligations of the parties regarding the governance of Acibadem Saglik Yatirimlari Holding A.S. and its group. 5. R ecurrent Related Party Transactions The recurrent related party transactions of a revenue nature incurred by the Group for FY2024 did not exceed the threshold prescribed under Paragraph 10.09(1) of the MMLR. Audit fees Non-Audit fees Group RM’million Company RM’million Group^ RM’million Company RM’million KPMG PLT 2 * 1 1 Affiliates of KPMG PLT 10 * 7 – Total 12 1 8 1 * Denotes balances of less than RM1 million ^ Approximately 58% and 38% of the non-audit fees are in relation to interim financial statements reviews and tax services respectively.
RkJQdWJsaXNoZXIy NDgzMzc=